FOR IMMEDIATE RELEASE
November 10, 2011
ApplicInt announces their partnership with BioSignia
Reno, NV (11.10.11) - ApplicInt, a technology solutions provider to
the Life and Health Insurance industry, today announced that they
have partnered with BioSignia to extend the automation of
BioSignia's Mortality Assessment Technology™ (MAT). Using the data
from ApplicInt's ExamComplete or CallComplete products, clients can
automatically feed BioSignia's MAT predictive underwriting
application to accurately evaluate an applicant's mortality risk,
based on underwriting criteria scientifically-proven to impact
mortality. MAT has been proven to allow carriers to price policies
more appropriately, offering preferred classifications to more
applicants, without increasing mortality risk.
Using ACORD standard XML, ExamComplete and CallComplete provide a
seamless interface that makes deploying MAT simple and
cost-effective, taking only weeks to implement. "In partnering with
BioSignia we have been able to increase the benefits associated with
our Part 2 product suite, providing an opportunity to further reduce
new business touches, data entry costs and cycle times." says
Michael Feroah, COO of ApplicInt.
MAT is the most comprehensive and accurate assessment tool available
today, and the connectivity available through the partnership
between ApplicInt and BioSignia presents the next step in true
electronic Straight Through Processing. "Partnering with ApplicInt
creates an easy to use solution set for life insurers interested in
streamlining the underwriting process," says John Schilhab, Sr. VP
of BioSignia. "We are excited about providing the market with a
simple, yet elegant solution that delivers value - both immediate
and long term."
MAT is available to ApplicInt's current ExamComplete and
CallComplete customers. For more information on BioSignia’s market
applications, please call 888.324.6627 or email email@example.com.
# # #
BioSignia is a leading technology company focused on bringing
innovative predictive modeling solutions to the life insurance and
preventive healthcare markets. BioSignia's patented technology,
Mortality Assessment Technology™ (MAT) represents a quantum leap
forward in both morbidity and mortality risk assessment. BioSignia's
talented R&D team continues to advance synthesis modeling,
continuously updating it to reflect the ever expanding need for
better risk assessment.
ApplicInt is the premier software provider for Insurance carriers.
The ApplicInt product set is uniquely positioned to allow its
carrier partners the agility and adaptability that is required in
today's fast moving business landscape. ApplicInt products
streamline the process of data collection by carriers from Agents,
Consumers, Call Centers and Examiners.